Sorry if I was unclear, I had no intention to imply that their innovation is weak, or that SV has anything to do with that. It's pretty clear they have access to SV network, despite being based in London.
Their logistics solution is just not as advanced as it can be. That's just common startup logic, the hardest problem will be solved with more money and good people and SV network has good people. They need combinatorial…
> Do you really think, that general populace's misuse of antibiotics could cause the development of resistant bacterial strains en masse? Of course not. There's 7 billion people, and just a tiny percentage uses…
Sorry if I was unclear, I had no intention to imply that their innovation is weak, or that SV has anything to do with that. It's pretty clear they have access to SV network, despite being based in London.
Their logistics solution is just not as advanced as it can be. That's just common startup logic, the hardest problem will be solved with more money and good people and SV network has good people. They need combinatorial…
> Do you really think, that general populace's misuse of antibiotics could cause the development of resistant bacterial strains en masse? Of course not. There's 7 billion people, and just a tiny percentage uses…